Provided is a novel use of a plasminogen activator inhibitor-1 inhibitor (PAI-1 inhibitor) that is used as an active ingredient of an agent for controlling a tumor stem cell, an agent for enhancing the antitumor effect of an antitumor agent, an agent for tumor chemotherapy, a stem-cell protecting drug, or a hematopoietic disorder improving agent.
本发明提供了一种纤溶酶原激活物
抑制剂-1
抑制剂(PAI-1
抑制剂)的新用途,该
抑制剂可用作控制肿瘤干细胞的药物、增强
抗肿瘤药物抗肿瘤效果的药物、肿瘤化疗药物、干细胞保护药物或改善造血障碍药物的活性成分。